Article
Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics
Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.
Related Videos
Related Content
